## **Core Concept**
The question revolves around the autoimmune disease Systemic Lupus Erythematosus (SLE) and its impact on pregnancy, specifically the risk of congenital heart disease in the offspring. SLE is characterized by the presence of various autoantibodies. One particular antibody is known to cross the placenta and affect the fetus.

## **Why the Correct Answer is Right**
The correct answer, **Anti-Ro/SSA and Anti-La/SSB antibodies**, are strongly associated with an increased risk of congenital heart block, a form of congenital heart disease, in the children of mothers with SLE. These antibodies can cross the placenta and target the fetal heart, leading to inflammation and damage to the heart's conduction system. The presence of these antibodies in mothers with SLE is a known risk factor for congenital complete heart block.

## **Why Each Wrong Option is Incorrect**
- **Option A:** This option is incorrect because while other autoantibodies are associated with SLE, they are not specifically implicated in congenital heart disease in the same way as Anti-Ro/SSA and Anti-La/SSB.
- **Option B:** Similarly, this option does not directly relate to the specific risk of congenital heart disease in children of mothers with SLE.
- **Option D:** This option is incorrect as it does not accurately represent the antibodies associated with congenital heart disease in the context of SLE.

## **Clinical Pearl / High-Yield Fact**
A key clinical pearl is that mothers with SLE who are positive for **Anti-Ro/SSA and Anti-La/SSB antibodies** should be closely monitored during pregnancy due to the increased risk of congenital heart block in their offspring. This monitoring often involves regular fetal echocardiograms to detect any cardiac abnormalities early.

## **Correct Answer:** . Anti-Ro/SSA and Anti-La/SSB antibodies